About NasrA. L., GazayerliM. E., FawziR. M.: Epidemiology and pathology of cancer of the bladder in Egypt. Acta Un. Internal. Contra Cancr., 18; 537 (1962).
2.
ArmstrongB., DollR.: Bladder cancer mortality in England and Wales in relation to cigarette smoking and saccharin consumption. Brit. J. Prev. Soc. Med., 28; 233 (1974).
3.
ArmstrongB., DollR.: Bladder cancer mortality in diabetics in relation to saccharin consumption and smoking habits. Brit. J. Prev. Soc. Med., 29; 73 (1975).
4.
AnsellI. D., CastroJ. E.: Carcinoma of the bladder complicating cyclophosphamide therapy. Brit. J. Urol., 47; 413 (1975).
5.
AnthonyH. M., ThomasG. M.: Bladder tumors and smoking. Intern. J. Cancer., 5; 226 (1976).
6.
BarkinM., ComiserowR. H., TarangerL. A., CanadaA.: Three cases of human bladder cancer following high dose cyclamate ingestion. J. Urol., 118; 258 (1977).
7.
BenassiC. A., PerissinottoB., AllegriG.: The metabolism of tryptophan in patients with bladder cancer and other urological diseases. Clin. Chem. Acta, 8; 822 (1963).
8.
BengtssonU., AngervallL.: Analgesic abuse and tumors of the renal pelvis. Lancet, 1; 305 (1970).
9.
BluemleL. W., GoldbergM.: Renal accumulation of salicylate and phenacetin possible mechanism in the nephropathy of analgesic abuse. J. Clin. Invest., 47; 257 (1968).
10.
BoylandE., WilliamsD. C.: The metabolism of tryptophan. The metabolism of tryptophan in patients suffering from cancer of the bladder. Biochem. J., 64; 578 (1956).
11.
BrownR. R., PriceJ. M., WearJ. B.: The metabolism of tryptophan in patients with bladder cancer. Acta Un. Internat. Contra Cancr., 16; 209 (1960).
12.
BrownR. R., PriceJ. M., FriedellG. H., BurneyS. V.: Tryptophan metabolism in patients with bladder cancer: geografical differences. J. Nat. Cancer Inst., 43; 295 (1969).
13.
BryanT., BrownR. R., PriceJ. M.: Mouse bladder carcinogenicity of certain tryptophan metabolites and other aromatic nitrogen compounds suspended in cholesterol. Cancer Res., 24; 596 (1964).
14.
CaseR. A. M., HoskerM. E., McDonaldD. B., PearsonJ. T.: Tumours of the urinary bladder in workmen engaged in the manifacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, alpha naphthylamine and beta-naphthylamine. Brit. J. Industr. Med., 11; 75 (1954).
15.
CaseR. A. M., PearsonJ. T.: Tumours of the urinary bladder in workmen engaged in the manifacture and use of certain dyestuff intermediates in the British chemical industry. Part H. Further consideration of the role of aniline and of manifacture of auramine and magenta (fuchsin) as possible causative agents. Brit. J. Indust. Med., 11; 213 (1954).
16.
CeovicS., GrimsP., MitarJ.: The incidence of tumours of the urinary organs in a region of endemic nephropathy and in a control region. Lijecn. Vjesn, 98; 301 (1976).
17.
ClemmensenJ., BremerskovV.: Parallel morbidity age curves for neoplasm of lung and bladder. Biomeédicine, 19; 198 (1973).
18.
ClemmensenJ., NielsenA.: Cancer incidence in Denmark 1943 to 1953. Tumours of the urinary system and prostate. Dan. Med. Bull., 3; 36 (1956).
19.
ChapmanW. H.: Role of urine in experimental bladder tumours. Surg. Fomm., 20; 520 (1969).
20.
ClaysonD. D., CooperE. H.: Cancer of the urinary tract. Adv. Cancer Res., 13; 271 (1970).
21.
ColeP., MonsonR. R., HaningH.: Smoking and cancer of the lower urnary tract. N. Eng. J. Med., 284; 129 (1971).
22.
ColeP.: Coffee drinking and cancer of the lower urinary tract. Lancet, 1; 1335 (1971).
23.
ColeP.: Cancer of the lower urinary tract. In: SchottenfeldD. ed.: Cancer Epidemiology and Prevention: Current Concepts.Charles C. Thomas, Springfield Ill., 1975.
24.
DollR., HillA. B.: Lung cancer and other causes of death in relation to smoking. A second report in the mortality of British doctor. Brit. Med. J., 2; 1071 (1956).
25.
DollR., HillA. B.: Mortality in relation to smoking. Ten years observation of British doctor. Brit. Med. J., 1; 1399 (1964).
26.
DunhamL. J., RabsonA. S., StewardH. J.: Rates, interview and pathology study of cancer of the urinary bladder in New Orleans, Lousiana. J. Nat. Cancer Inst., 41; 683 (1968).
27.
DunningW. F., CurtisM. R.: Further studies on the relation of dietary tryptophan to the induction of neoplasm in rats. Cancer Res., 14; 299 (1954).
28.
DunningW. F., CurtisM. R., MaunM. E.: The effect of added dietary tryptophan on the occurence of 2-acetylaminofluorene induced liver and bladder cancer in rats. Cancer Res., 10; 454 (1950).
29.
EgerbergO., SteinfeldJ. L., FrantzI.: Report to the secretary of Hew from the medical advisory Groups on Cyclamates. J.A.M.A., 211; 1358 (1970).
30.
ElliottA. Y., FraleyE. R., CastroA. E.: Isolation of an RNA virus from transitional cell tumours of the human urinary bladder. Surgery, 74; 46 (1973).
31.
EkmanB., StrombeckJ. P.: Demonstration of tumorigenic decomposition products of 2,3-azotoluene. Acta Physiol. Scand., 14; 43 (1947).
32.
EvansJ. A.: Radiomimetic nature of brocken toxin. Cancer Res., 28; 2252 (1968).
33.
FergusonA. R.: Associated bilharziosis and primary malignant disease of the urinary bladder with observations an a series of forty cases. J. Pathol. Bacteriol., 16; 76 (1911).
34.
FraleyE. E., ElliottA. Y., ClevelandP., SteinN.: Rna-virus associated with human transitional cell cancer of the urinary tract. Minerva Med., 57; 871 (1974).
35.
GaakeerH. A., De RuiterH. J.: Carcinoma of the renal pelvis following the abuse of phenacetin-containing analgesic drugs. Brit. J. Urol., 51; 188 (1979).
36.
GardnerS., FieldA. M., ColemanD. V.: New human Papovavirus (B. K.) isolated from urine after renal transplantation. Lancet, 1; 1253 (1971).
37.
GelfandM., WeinbergR. W., CastleW. M.: Relation between carcinoma of the bladder and infestation with Schistosoma haematobium. Lancet, 1; 1249 (1967).
38.
GillmanH., PratesM. D.: Histological types of histogenesis of bladder cancer in the Portoguese East Agrican with special reference to bilharzial cystitis. Acta Un. Internat. Contra Cancr., 18; 560 (1962).
39.
GonodJ. W., JennerP., KeysellG. R., MikhaelB. R.: Oxidative metabolism of nicotine by cigarette smokers with cancer of the urinary bladder. J. Nat. Cancer Inst., 52; 1421 (1974).
40.
HicksR. M., WaltersC. L., ElsebaiI.: Demonstration of nitrosamine in human urine: preliminary observations on a possible etiology for bladder cancer in association with chronic urinary tract infections. Proc. R. Soc. Med., 70; 413 (1977).
41.
HicksR. M., ChaowaniecJ.: The importance of synergy between weak carcinogens in the induction of bladder cancer in experimental animals and humans. Cancer Res., 37; 2943 (1977).
42.
HinderR. A., SchmannA.: Bilharziosis and squamous carcinoma of the bladder. S. Afr. Med. J., 43; 617 (1969).
43.
HoweG. R., BurchJ. D., MillerA. B.: Artificial sweeteners and human bladder cancer. Lancet, 2; 578 (1977).
44.
HueperW. C.: Occupational and environmental cancers of the urinary system.New Haven, Yale University Press, pag. 276 (1969).
45.
HultengrenN., LagergrenC., LjungqristA.: Carcinoma of the renal pelvis in renal papillary necrosis. Acta Clin. Scand., 130; 314 (1965).
46.
JohnsonW. W., MeadowsD. C.: Urinary bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. N. Engl. J. Med., 284; 290 (1971).
47.
JuuselaH.: Carcinoma of the renal pelvis and its relathionship to analgesic abuse. Ann. Chir. Gynaec. Fenn., 62/6; 386 (1973).
48.
KerrW. K., BarkinM., ToddI. A. D., MenczykZ.: A hypernephroma associated with elevated levels of carcinogens in the urine. Brit. J. Urol., 35; 263 (1963).
49.
KerrW. K., BarkinM., LeversP. E., WooS. K. C., MenczykZ.: Effects of smoking on bladder carcinogens. Canad. Med. J., 95; 1 (1965).
50.
KesslerI. I., Page-ClarkJ.: Saccharin, Cyclamate and human bladder cancer. J.A.M.A., 240; 4/349 (1978).
51.
KingH., BailarJ. C.: Eepidemiology urinary bladder cancer. A review of selected literature. J. Chronic. Dis., 19; 735 (1966).
PrescottL. F.: Antipyretic analgesic in Meyler's side. Effects of drugs.Ed. Dukes M. N. G., pag. 154–240 (1975).
63.
PriceJ. M., BrownR. R.: Studies on the etiology of carcinoma of the urinary bladder. Acta Un. Internat. Contra Cancr., 18; 684 (1962).
64.
PriceJ. M.: Bladder cancer. Canadian cancer conference. Preceedings of the sixth Cancer Research Conference. Pergamon Press, New York1966.
65.
PriceJ. M.: Personal communication. In < Total urothelial neoplasia >, Wallace D. M. (1971).
66.
RadomskiJ. L., GreenwaldD., HearnW. L., BlockN. L., WoodsF. M.: Nitrosamine formation in bladder infections and its role in the etiology of bladder cancer. J. Urol., 120; 48 (1978).
67.
RathertP., HansjorgM., LutzeyerW.: Phenacetin: a carcinogen for the urinary tract? J. Urol., 113; 653 (1975).
68.
RehnL.: Blasengeschwulste bei fuchsin-arbeitern. Arch. klin. Chir., 50; 588 (1895).
69.
RehnL.: über Blasenerkrankungen bei Anilinarbeitern. Verh. dtsch. Ges. Chir., 35; 313 (1906).
70.
RomasN. A., IonascuL., SholemS., IonescuG., VeenemaR. J.: A new method for determination of urinary tryptophan metabolites in bladder carcinoma. J. Urol., 114; 223 (1975).
71.
SattlerT. A., DimitrovT. S., HallP. W.: Relation between endemic (balkan) nephropathy and urinary tract tumours. Lancet, 5; 278 (1977).
72.
ScottT. S.: Carcinogenic and chronic toxic hazards of aromatic amines.Elsevier, Amsterdam1962.
73.
ShahK. V.: Investigation of human malignant tumours in India for simian virus 40 etiology. J. Nat. Cancer Inst., 41; 139 (1969).
74.
ShahK. V., PalmaL. D., MurphyG. P.: The occurence of SV 40 neutralizing antibiodies in sera of patients with genitourinary carcinoma. J. Surg. Oncol., 3; 443 (1971).
75.
ShahK. V., PondH.: Attempts to produce urinary bladder cancer in dogs by inoculation of simian virus 40 into the urothelium. Invest. Urol., 10; 141 (1972).
76.
SchmählD.: Saccharin und blasenkrebs. Wschr., 3; 103 (1978).
77.
SorrentinoF., De MartinoA. M.: Chronic interstitial nephroritis as a cause of tumours of the upper urinary tract. A hypothesis. Urol. Intern., 34; 393 (1979).
78.
StewartJ. H., GalleryE. D. M.: Analgesuc abuse and kidney disease. Aus. N. Z. J. Med., 6; 498 (1976).
79.
StoneD., LamsonE., ChangY. S., PickeringK. W.: Cytogenic effects of cyclamates on human cell in vitro. Science, 164; 568 (1969).
80.
StoreyB. G., MahonyJ. F., StewartJ. H.: Carcinoma of the upper urinary tract associated with analgesic nephropathy. Brit. J. Urol., 49; 242 (1977).
TosiS. E., MorinL. E.: Bladder tumor associated with phenacetin abuse. Urology, 9; 59 (1977).
83.
YoshidaO., BrownR. R., BryanG. T.: Relationship between tryptophan metabolism and heterotopic recurrences of human urinary bladder tumours. Cancer, 24; 773 (1969).
84.
WallR. L., ClausenK. P.: Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N. Engl. J. Med., 7; 271 (1975).
85.
WallaceD. M.: Total urothelial neoplasia. In < The biology and clinical management of bladder cancer >. Ed. CooperE. H. and WilliamsR. E., pag. 255 (1975).
86.
WinderE. L., OnderdonkJ., MantelN.: An epidemiological investigation of cancer of the bladder. Cancer, 16; 1388 (1963).
87.
WinderE. L., GoldsmithR.: The epidemiology of bladder cancer. A second look. Cancer, 40; 1246 (1977).